ONCOtracker, Inc

📍 West Hollywood, United States🗓 Founded 2015👥 5 employees💰 Last funded Sep 2023
Biotechnology Research🌐 oncotracker.com
Website LinkedIn
Founded by myeloma research pioneer and oncologist, James R. Berenson, M.D., OncoTracker provides proprietary serum BCMA testing, patient-derived xenografts (PDX), access to an ongoing extensive library of clinically characterized biospecimens, and consultative services, to help pharmaceutical and biotechnology companies develop and evaluate new drugs. OncoTracker’s facilities, including a state-of-the-art GLP laboratory and biorepository, are ideally suited to support drug development and clinical studies worldwide. Located in West Hollywood, CA, the company has provided critical testing, biospecimens, patient-derived xenografts and consultative guidance to research institutions, pharmaceutical companies and contract research organizations around the world to further the development of BCMA-directed drugs. OncoTracker welcomes the opportunity to discuss how its unique testing services and programs may help your drug development needs.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ONCOtracker, Inc?
ONCOtracker, Inc has 1 investors on record on gritt.io and 1 late-stage investors.
When did ONCOtracker, Inc last raise funding?
The most recent investment in ONCOtracker, Inc recorded on gritt.io was in September 2023.
When was ONCOtracker, Inc founded?
ONCOtracker, Inc was founded in 2015.
What industry is ONCOtracker, Inc in?
ONCOtracker, Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ONCOtracker, Inc based?
ONCOtracker, Inc is headquartered in West Hollywood, United States.